Related Experiment Video
Updated: Jun 11, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Pulmonary hypertension in heart failure
1Department of Cardiology, University of South Florida, Tampa, Florida 33618, USA. mguglin@health.usf.edu
Pulmonary hypertension is common in heart failure patients, impacting survival. It can improve with treatment addressing cardiac pressures and may benefit from interventions targeting vascular remodeling.
Area of Science:
- Cardiology
- Pulmonary Medicine
Background:
- Pulmonary hypertension affects 60-80% of heart failure patients.
- Associated with significant morbidity and mortality.
Purpose of the Study:
- To explore the nature and potential treatments for pulmonary hypertension in heart failure.
Main Methods:
- Correlation analysis of pulmonary artery pressure and left ventricular end-diastolic pressure.
- Assessment of reversibility with pressure normalization and interventions.
Main Results:
- Pulmonary hypertension is linked to elevated left ventricular end-diastolic pressure.
- It is prevalent in both preserved and reduced ejection fraction heart failure.
- Partially reversible with normalized filling pressures; vascular remodeling may improve with specific therapies.
Conclusions:
- Investigating idiopathic pulmonary arterial hypertension drugs for heart failure-related pulmonary hypertension is warranted.
- Left ventricular assist devices show promise for improving vascular remodeling.
- Further clinical trials are needed for heart failure patients with elevated pulmonary artery pressure.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Heart Failure II: Pathophysiology
